epigallocatechin gallate has been researched along with Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poomalai, S; Selvaraj, M; Shanmugam, T | 1 |
| Hsieh, PW; Lee, CY; Lee, IT; Lin, CC; Yang, CM | 1 |
2 other study(ies) available for epigallocatechin gallate and Pneumonia
| Article | Year |
|---|---|
Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Fluorides; Inflammation Mediators; Kelch-Like ECH-Associated Protein 1; Lung; Male; NF-E2-Related Factor 2; Oxidative Stress; Pneumonia; Rats; Rats, Wistar; Signal Transduction | 2016 |
Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition.
Topics: Activating Transcription Factor 2; Animals; Catechin; Cell Line; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Humans; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred ICR; NADPH Oxidases; Phosphorylation; Pneumonia; Protective Agents; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Type I; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; TNF Receptor-Associated Factor 2; Tumor Necrosis Factor-alpha | 2013 |